Chuck Royce's IRWD Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 18,553 shares of Ironwood Pharmaceuticals, Inc. (IRWD) worth $78,108, representing 0.00% of the portfolio. First purchased in 2020-Q1, this long-term strategic position has been held for 21 quarters.
Based on 13F filings, Chuck Royce has maintained a strategic position in IRWD, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2022, adding 679,997 shares. Largest reduction occurred in Q2 2023, reducing 1.6 M shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Ironwood Pharmaceuticals (IRWD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Ironwood Pharmaceuticals (IRWD) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +18,553 | New Buy | 18,553 | $4.21 |
| Q4 2025 | -300,619 | Sold Out | 0 | $0.00 |
| Q3 2025 | -205,441 | Reduce 40.60% | 300,619 | $1.31 |
| Q2 2025 | -229,376 | Reduce 31.19% | 506,060 | $0.72 |
| Q4 2024 | +72,502 | Add 10.94% | 735,436 | $4.43 |
| Q3 2024 | +64,353 | Add 10.75% | 662,934 | $4.12 |
| Q2 2024 | +7,577 | Add 1.28% | 598,581 | $6.52 |
| Q1 2024 | +292,241 | Add 97.82% | 591,004 | $8.71 |
| Q4 2023 | +14,013 | Add 4.92% | 298,763 | $11.44 |
| Q3 2023 | +2,130 | Add 0.75% | 284,750 | $9.63 |
| Q2 2023 | -1.6 M | Reduce 85.02% | 282,620 | $10.64 |
| Q1 2023 | +210,758 | Add 12.58% | 1.89 M | $10.52 |
| Q4 2022 | -2,722 | Reduce 0.16% | 1.68 M | $12.39 |
| Q3 2022 | +184,574 | Add 12.36% | 1.68 M | $10.36 |
| Q2 2022 | +332,791 | Add 28.67% | 1.49 M | $11.53 |
| Q1 2022 | +679,997 | Add 141.42% | 1.16 M | $12.58 |
| Q4 2021 | +480,849 | New Buy | 480,849 | $11.66 |
| Q3 2020 | -2,328 | Sold Out | 0 | $0.00 |
| Q2 2020 | +463 | Add 24.83% | 2,328 | $10.31 |
| Q1 2020 | +1,865 | New Buy | 1,865 | $10.19 |
Chuck Royce's Ironwood Pharmaceuticals Investment FAQs
Chuck Royce first purchased Ironwood Pharmaceuticals, Inc. (IRWD) in Q1 2020, acquiring 1,865 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Ironwood Pharmaceuticals, Inc. (IRWD) for 21 quarters since Q1 2020.
Chuck Royce's largest addition to Ironwood Pharmaceuticals, Inc. (IRWD) was in Q1 2022, adding 1,160,846 shares worth $14.6 M.
According to the latest 13F filing for Q2 2026, Chuck Royce's firm, Royce & Associates Lp, owns 18,553 shares of Ironwood Pharmaceuticals, Inc. (IRWD), valued at approximately $78,108.
As of the Q2 2026 filing, Ironwood Pharmaceuticals, Inc. (IRWD) represents approximately 0.00% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Ironwood Pharmaceuticals, Inc. (IRWD) was 1,886,247 shares, as reported at the end of Q1 2023.